A Prospective, Open-label, Controlled, Single Center Clinical Study of the Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis
Latest Information Update: 03 Aug 2023
At a glance
- Drugs Azathioprine (Primary) ; Telitacicept (Primary)
- Indications Anti-neutrophil cytoplasmic antibody-associated vasculitis; Granulomatosis with polyangiitis; Microscopic polyangiitis
- Focus Therapeutic Use
- Acronyms TTCAZAREM
Most Recent Events
- 03 Aug 2023 New trial record